Back to Agenda
Global Perspectives on Patient Engagement
Session Chair(s)
Mathieu Boudes, PHD
Patient Engagement Director, Montsouris Consilium, France
In Europe and North America, patient engagement in drug development is now expected, though not perfect. In this session, a panel of patient, industry, and regulator stakeholders will discuss the thinking and initiatives in other global regions to give patients a voice. We will look beyond Europe and North America to explore the thinking and efforts in other regions to engage patients in the medical product lifecycle. What efforts are underway or emerging to give patients a voice? What cultural, societal, and economic factors drive current thoughts and practices? Who are the influencers who are encouraging change? A diverse panel representing patient groups, regulators and industry from regions such as Asia and Latin America will talk about current experience, hopes, and aspirations for patient engagement worldwide.
Learning Objective : Describe current practices for patient engagement in drug development and regulation in regions such as Asia and Latin America; Compare and contrast perspectives of patient, industry, and regulator stakeholders within these regions; Discuss cultural, societal, and other factors playing a role in views, practices, and emerging trends on patient engagement in these regions.
Speaker(s)
Junko Sato, PHD
Associate Executive Director, Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Jan Nissen, BSN, MBA, MS
Former, Vice President, Patient Innovation and Engagement, Merck & Co., Inc., Consultant, United States
Durhane Wong-Rieger, PHD, MA
President and Chief Executive Officer, Canadian Organization For Rare Disorders, Canada
Young Jack Lee, PHD
Chief Executive Officer, LSK Global Pharma Services, Korea, Republic of
Jieun Lee, RPH
Assistant Director, Ministry of Food and Drugs Safety, Korea, Republic of
Have an account?